We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Culture Medium Developed for Pathogenic Free-Living Amoeba

By LabMedica International staff writers
Posted on 19 Aug 2015
Balamuthia mandrillaris is an opportunistic protist pathogen and the causative agent of necrotizing hemorrhagic granulomatous encephalitis among other infections, with an estimated fatality rate approaching 98%.

B. More...
mandrillaris, unlike most of other free-living amoebae, does not feed on Gram-negative bacteria and therefore the use of non-nutrient agar coated with bacterial cultures has resulted to be ineffective for its growth. Other special medium have been recommended, but they have some disadvantages, as they require many components and their preparations are laborious.

Microbiologists at the Sonora Technological Institute (Mexico) developed an easy-to-prepare culture medium for axenic growth of B. mandrillaris using Cerva's medium as basal component. Ten strains of B. mandrillaris including a well-characterized US Centers for Disease and Prevention (CDC; Atlanta, GA, USA) reference stain and nine environmental isolates from water and soil were used during the study.

Each one of the 11 components of BM-3 culture medium was combined with Cerva's medium as basal culture medium. The cultures were observed daily for a four-week period under an inverted microscope Axiovert 135 (Zeiss; Gottingen, Germany). The number of trophozoites/mL was determined using a hemocytometer, and the doubling time was calculated by linear regression. The yields in each culture were determined at the end of the logarithmic growth phase.

After the first week of daily observations of the tested combinations of BM-3 components and Cerva's medium, amoebae numbers diminished in every flask. At the end of the second week of incubation, neither trophozoites nor cysts were seen in any modification, except for the one consisting of the basal medium complemented with 10× Hank's balanced salt solution (34.0 mL/500 mL) where growth was recovered. Hank's balanced salt solution was the only one that supported confluent growth of B. mandrillaris and where cell shape and motility of trophozoites were normal.

The authors concluded that nutrimental necessity of B. mandrillaris depends on adequate salt solution, protein extracts, and other nutrients obtained from the fetal bovine serum. When using axenic cultures, the development of a cheaper and easy-to-prepare medium for B. mandrillaris opens the possibility of increasing our knowledge on this lethal pathogen. (The study was published in the August 2015 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Sonora Technological Institute 
Zeiss 



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.